阿齊沙坦酯雜質(zhì)D對照品

1-[[2-(2,5-二氫-5-氧代-1,2,4-噁二唑-3-基)[1,1-聯(lián)苯]-4-基]甲基]-2-乙氧基-1H-苯并咪唑-7-羧酸甲酯;2-乙氧基-1'（（2'-4,5,-氧代-1,2,4-惡二唑-3-基）聯(lián)苯-4-基）甲基）苯并咪唑-7-羧酸甲酯;阿齊沙坦甲酯;阿齊沙坦雜質(zhì)M;二(異丙基氧)雙(2,2,6,6-四甲基-3,5-癸烷)鈦;1-[(2'-[(乙氧羰基)氧基]脒基)[1,1-聯(lián)苯基]-4-基)甲基]-2-乙氧基-1H-苯并咪唑-7-甲酸甲酯;1-[[2'-(2,5-二氫-5-氧代-1,2,4-惡二唑-3-基)[1,1－聯(lián)苯基]-4-基)甲基]-2-乙氧基-1H-苯并咪唑-7-甲酸甲酯;阿齊沙坦-a04;1-[[2'-(2,5-二氫-5-氧代-1,2,4-噁二唑-3-基)[1,1-聯(lián)苯]-4-基]甲基]-2-乙氧基-1H-苯并咪唑-7-羧酸甲酯;阿齊沙;阿齊沙坦酯雜質(zhì)D;阿齊沙坦INT D;阿齊沙坦中間體(A2甲酯);1-[[2'-(5-氧代-4,5二氫-1,2,4-噁二唑-3基)聯(lián)苯-4-基]甲基]-1H-苯并咪唑-2-乙氧基-7-羧酸甲酯;2-乙氧基-1-[(2'-(5-氧代-4,5-二氫-1,2,4-噁二唑-3-基)聯(lián)苯-4-基]甲基-1H-苯并[D]咪唑-7-甲酸甲酯;1-[[2'-(2,5-二氫-5-氧代-1,2,4-二唑-3-基)[1,1-聯(lián)苯]-4-基]甲基]-2-乙氧基-1H-苯并咪唑-7-羧酸甲酯

methyl 2-ethoxy-1-((2'-(5-oxo-4,5-dihydro-1,2,4-oxadiazol-3-yl)-[1,1'-biphenyl]-4-yl)methyl)-1H-benzo[d]imidazole-7-carboxylate

1H-Benzimidazole-7-carboxylic acid, 1-[[2'-(2,5-dihydro-5-oxo-1,2,4-oxadiazol-3-yl)[1,1'-biphenyl]-4-yl]methyl] -2-ethoxy-, methyl ester;1-[[2'-(2,5-Dihydro-5-oxo-1,2,4-oxadiazol-3-yl)[1,1'-biphenyl]-4-yl]methyl]-2-ethoxy-1H-benzimidazole-7-carboxylic acid methyl ester;1H-Benzimidazole-7-carboxylic acid, 1-[[2'-(2,5-dihydro-5-oxo-1,2,4-oxadiazol-3-yl)[1,1'-biphenyl]-4-yl]methyl] -2-ethoxy-, m;AQ-2;Azilsartan;Azilsartan intermediate;methyl 2-ethoxy-3-[[4-[2-(5-oxo-2H-1,2,4-oxadiazol-3-yl)phenyl]phenyl]methyl]benzimidazole-4-carboxylate;Methyl 2-ethoxy-1-((2'-(5-oxo-2,5-dihydro-1,2,4-oxadiazol-3-yl)-[1,1'-biphenyl]-4-yl)methyl)-1H-benzo[d]imidazole-7-carboxylate;methyl 2-ethoxy-1-((2'-(5-oxo-4,5-dihydro-1,2,4-oxadiazol-3-yl)-[1,1'-biphenyl]-4-yl)methyl)-1H-benzo[d]imidazole-7-carboxylate;methyl 2-ethoxy-1-{[2'-(5-oxo-4,5-dihydro-1,2,4-oxadiazol-3-yl)biphenyl-4-yl]methyl}-1H-benzimidazole-7-carboxylate;Azilsartan Methyl ester;AzilsartanMedoxoMilInterMediates-2;1H-BenziMidazole-7-carboxylic acid, 1-[[2'-(2,5-dihydro-5-oxo-1,2,4-oxadiazol-3-yl)[1,1'-biphenyl]-4;1-[[2'-(2,5-dihydro-5-oxo-1,2,4-oxadiazol-3-yl)[1,1'-biphenyl]-4-yl]Methyl] -2-ethoxy-, Methyl ester;Methyl 2-ethoxy-1-((2'-(5-oxo-4,5-dihydro-1,2,4-oxadiazol-3-yl)biphenyl-4-yl)Methyl)-1H-benzo[d]iMidazole-7-carboxylate;Methyl 2-ethoxy-1-((2'-(5-oxo-2,5-dihydro-1,2,4-oxadiazol-3-yl)biphenyl-4-yl)Methyl)-1H-benzo[d]iMidazole-7-carboxylate;(Z)-Methyl 2-ethoxy-3-((2'-(N'-(ethoxycarbonyloxy)carbaMiMidoyl)biphenyl-4-yl)Methyl)-3H-benzo[d]iMidazole-4-carboxylate;Methyl 1-[[2'-(2,5-Dihydro-5-oxo-4H-1,2,4-oxadiazol-3-yl)biphenyl-4-yl] methyl] -2-ethoxy-1H-benzimidazole-7-carboxylate;AK164568;1H-Benzimidazole-7-carboxylic acid, 1-[[2'-(2,5-dihydro-5-oxo-1,2,4-oxadiazol-3-yl)[1,1'-biphenyl]-4-yl]methyl]-2-ethoxy-, methyl ester;1-[[2'-(2,5-Dihydro-5-oxo-1,2,4-oxadiazol-3-yl)[1,1'-biphenyl]-4-yl]Methyl]-2-ethoxy-1H-benziMidazole-7-carbox;Methyl 2-ethoxy-3-[[4-[2-(5-oxo-4H-1,2,4-oxadiazol-3-yl)phenyl]phenyl]methyl]benzimidazole-4-carboxy

147403-52-9

C₂₆H₂₂N₄O₅

470.48

僅用于研發(fā)試驗(yàn)中鑒別、檢查。147403-52-9|阿齊沙坦酯雜質(zhì)D對照品,≥99%，制備中，詳情請聯(lián)系Medlife客服進(jìn)行咨詢。methyl 2-ethoxy-1-((2'-(5-oxo-4,5-dihydro-1,2,4-oxadiazol-3-yl)-[1,1'-biphenyl]-4-yl)methyl)-1H-benzo[d]imidazole-7-carboxylate可放大生產(chǎn)，批量保障。